This illustration provided by AstraZeneca depicts packaging for their medication Beyfortus. U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year. The Food and Drug Administration on Monday, July 17, 2023 approved the injection for infants and children up to 2 years old. (AstraZeneca via AP)
By Matthew Perrone
U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.
“Today’s approval addresses the great need for products to help reduce the impact of RSV disease on children, families and the health care system” said FDA's Dr. John Farley in a statement.
Last year, a surge in RSV cases flooded U.S. hospitals with wheezing children. There are no vaccines for babies yet, though Pfizer and other companies are working on them.
AstraZeneca’s drug, to be sold under the brand name Beyfortus, is a laboratory-made version of an antibody that helps the immune system fight off RSV. Under the FDA approval, babies — including preterm infants — can receive a single injection to protect against their first season of RSV, which typically lasts about five months. Children up to age 2 can receive another dose to protect them during their second season facing the virus.
Beyfortus, which will be marketed in the U.S. by Sanofi, is already approved in Canada, Europe and the U.K. Sanofi did not immediately announce the U.S. price of the treatment.
FDA officials approved the drug based on three studies showing Beyfortus reduced the risk of RSV infection between 70% and 75% among infants and children 2 and younger.
Advisers to the Centers for Disease Control and Prevention will meet early next month to recommend exactly who should get the drug.
A similar antibody drug won FDA approval more than 20 years ago, but it’s only recommended for high-risk babies and requires monthly injections. Pediatricians say the drug is underutilized and they expect the longer-lasting effect of AstraZeneca's shot to improve uptake.
In the U.S., about 58,000 children younger than 5 are hospitalized for RSV each year and several hundred die.
After decades of setbacks for RSV research, drugmakers have made big strides this year, launching the first vaccines against the virus. In May, the FDA approved two RSV vaccines for older adults from GlaxoSmithKline and Pfizer. In August, the FDA is expected to make a decision on approving Pfizer’s vaccine for pregnant women, with the aim of passing along protection to their newborns.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
In a nearly 3,700 page UN report, climate scientists outline the imminent dangers caused by climate change, saying fossil fuels are 'choking humanity.' The report calls some of the impacts of global warming 'irreversible,' warning of extreme consequences in the near future. Kristie L. Ebi, Professor of Global Health and Environmental and Occupational Health Sciences, University of Washington joined Cheddar's Opening Bell to discuss.
World leaders are currently dealing with a handful of pressing issues, including Russia's invasion of Ukraine, inflation, and not to mention the COVID-19 pandemic; but it could be argued that the most pressing issue is one that has experienced its fair share of neglect in the past -- climate change. As tensions escalate between Russia and Ukraine, there is fear the focus on climate will once again be pushed aside. However, the White House appears to be making some effort to prevent that from happening. The White House Office of Science and Technology held a first-of-its-kind roundtable discussion with some of the nation's leading climate scientists on Thursday. Michael Mann, Director of the Earth System Science Center at Pennsylvania State University, and author of the book 'The New Climate War' joins Cheddar News' Closing Bell to discuss his experience as one of the climate scientists at the White House event.
On December 25, 2021, NASA got into the holiday spirit by launching the James Webb Space Telescope, the largest and most powerful space science observatory in history.
It is intended to succeed the Hubble Space Telescope as NASA's flagship mission in astrophysics and is able to view objects too old and distant for Hubble. Gregory Robinson, director of NASA's James Webb Space Telescope program, joins Cheddar News' Closing Bell to discuss the mission. "I think a lot of what we don't know today is what I'm expecting to find and certainly really understand what took place more than 13.5 billion years ago and see the formation of some of the first galaxies in our universe," said Robinson.
The COVID-19 pandemic disrupted blood donations leading to severe shortages throughout the country. Chloe Aiello reports on the desperate need for new donors.
GSK has unveiled its new consumer health unit called Haelon. Haleon will debut as a standalone company later this year. Katie Williams, U.S. chief marketing officer at GSK, joined Cheddar News to discuss.
Even amid the Great Resignation, the cannabis industry saw major job growth. As of January 2022, the legal industry supported more than 428,000 jobs — a 33 percent increase year-over-year, according to the sixth annual jobs report from Leafly, a website focused on cannabis use and education. Yoko Miyashita, CEO of Leafly, joined Cheddar News' Closing Bell to discuss. “You know we've got big moments coming ahead in New Jersey and New York with adult-use sales starting in New Jersey, hopefully by this fall, with New York quickly to follow," she said. "So we're hugely optimistic about the kind of job growth that those markets can drive with the right type of market setup.
DNA evidence now shows that the 500-pound black bear the public had nicknamed “Hank the Tank” is, in fact, three not-so-little bears who have damaged more than 30 properties around Lake Tahoe in recent months.
The Biden administration will significantly loosen federal mask-wearing guidelines to protect against COVID-19 transmission on Friday, according to two people familiar with the matter.
